CD274 and neoplasm: The level of chronic inflammation, expression of PD1 and PD-L1, and biomarkers of total T lymphocytes (CD3), cytotoxic “effector” T cells (CD8) and tumor-associated macrophages (CD68) were evaluated using a scoring system as described in Material and methods.